No Data
Guolian Securities: The continuous advancement of prescription outflow and the increase in the concentration of retail pharmacies.
With the gradual opening of outpatient services to retail pharmacies, the health insurance bureau has issued multiple documents in recent times to strengthen the management of the use of medical insurance funds by designated retail pharmacies, with the hope of promoting the concentration of market share in pharmacies with stronger compliance awareness.
Yunnan Jianzhijia Health-Chain (605266.SH) completes its employee stock ownership plan purchase in 2024.
On July 18th, Gelonhui reported that Yunnan Jianzhijia health-chain (605266.SH) announced that the company's board of directors completed the account opening procedures for the "Yunnan Jianzhijia Pharmaceutical Chain Group Co., Ltd. - 2024 Employee Stock Ownership Plan" securities account on June 19, 2024, based on the employee shareholding plan and the authorization of the shareholder meeting. As of the close of July 18, 2024, the employee stock ownership plan has cumulatively bought 2.0512 million shares of the company's stock in the secondary market, accounting for 1.3087% of the company's total share capital of 156,736,538 shares, with a transaction amount of 49.9956 million yuan and an average transaction price of 24.3.
Jianzhijia Pharmaceutical Chain Group Co., Ltd.'s (SHSE:605266) Market Cap Dropped CN¥417m Last Week; Individual Investors Who Hold 31% Were Hit as Were Institutions
Yunnan Jianzhijia Health-Chain (605266.SH): Cumulative repurchase of 0.73% of company shares.
Yunnan Jianzhijia Health-Chain (605266.SH) announced on July 11th that as of the disclosure date of this announcement, the company has actually repurchased 1.1433 million shares of the company through the Shanghai Stock Exchange's centralized bidding trading method, accounting for 0.73% of the company's total share capital of 156,736,538 shares. The repurchase transaction price was 21.56-29.99 yuan per share, and the total amount of funds used was 29.9815 million yuan (excluding transaction costs).
Announcement of expected semi-annual performance decrease in 2024.
Yunnan Jianzhijia Health-Chain (605266.SH): Cumulative repurchase of 0.55% of the company's shares.
Yunnan Jianzhijia Health-Chain (605266.SH) announced that as of June 30, 2024, the company has repurchased a total of 855,460 shares through the Shanghai Stock Exchange's centralized bidding trading method, accounting for 0.55% of the company's total share capital of 154,618,658 shares. The minimum and maximum repurchase prices were 25.96 yuan/share and 29.99 yuan/share respectively, and the total amount of funds used was 23.7137 million yuan (excluding transaction costs).
Jianzhijia Pharmaceutical Chain Group Co., Ltd. (SHSE:605266) Looks Inexpensive But Perhaps Not Attractive EnoughNo Data
